Dentistry Medical News about Intrabony Periodontal Defects

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
New Certification for Hermatology-Oncology Coding

Dorothy J. Schirf, MD

Technology Advances

Imaging Advance Takes On MRI Cancer Sensitivity

Sara Hartley

Technology Advances

A New Strategy for Protecting Ovaries in Young Cancer Patients

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clinical and Histological Evaluation of Granular Beta Tricalcium Phosphate for the Treatment of Human Intrabony Periodontal Defects. A Report on Five Cases
Journal of Periodontology, 11/06/09

Stavropoulos A et al. – The present data indicate that treatment of intrabony periodontal defects with this beta–TCP may result in substantial clinical improvements such as PD reduction and CAL gain, but does not seem to enhance regeneration of cementum, periodontal ligament and bone.

<< Previous
Fresh socket implants in periapical infected sites in humans

Next >>
Reducing Ventilator-Associated Pneumonia Through Advanced...